These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 35467162)
61. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Parkes SN; Bersten AD Thorax; 1997 Feb; 52(2):171-5. PubMed ID: 9059480 [TBL] [Abstract][Full Text] [Related]
62. The effect of benzalkonium chloride on the bronchodilator response to salbutamol nebuliser solution. Kwong T; Flatt A; Crane J; Beasley R N Z Med J; 1990 Sep; 103(898):457. PubMed ID: 2216117 [No Abstract] [Full Text] [Related]
63. Effects of Fill Volume and Humidification on Aerosol Delivery During Single-Limb Noninvasive Ventilation. Saeed H; Mohsen M; Salah Eldin A; Elberry AA; Hussein RR; Rabea H; Abdelrahim ME Respir Care; 2018 Nov; 63(11):1370-1378. PubMed ID: 30108135 [TBL] [Abstract][Full Text] [Related]
64. Microbial contamination of domiciliary nebuliser therapy equipment. Jones PD; Moritz V; Pierce RJ Aust N Z J Med; 1985 Oct; 15(5):585-9. PubMed ID: 3867335 [TBL] [Abstract][Full Text] [Related]
65. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. Dennis JH; Stenton SC; Beach JR; Avery AJ; Walters EH; Hendrick DJ Thorax; 1990 Oct; 45(10):728-32. PubMed ID: 2247862 [TBL] [Abstract][Full Text] [Related]
66. [Salbutamol in asthmatic children, lung function and plasma levels of free salbutamol after treatment with salbutamol rectally and by pressurized aerosol (author's transl)]. Stemmann EA; Wolff GE Monatsschr Kinderheilkd (1902); 1980 Feb; 128(2):89-92. PubMed ID: 7360138 [TBL] [Abstract][Full Text] [Related]
67. Dose-related bronchodilator response to aerosolized salbutamol (albuterol) in ventilator-dependent premature infants. Denjean A; Guimaraes H; Migdal M; Miramand JL; Dehan M; Gaultier C J Pediatr; 1992 Jun; 120(6):974-9. PubMed ID: 1593360 [TBL] [Abstract][Full Text] [Related]
69. Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients. Moustafa IOF; Ali MRA; Al Hallag M; Rabea H; Fink JB; Dailey P; Abdelrahim MEA Heart Lung; 2017; 46(6):464-467. PubMed ID: 28882385 [TBL] [Abstract][Full Text] [Related]
70. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551 [TBL] [Abstract][Full Text] [Related]
72. Effectiveness of nebulised salbutamol administered in ambulances to patients with severe acute asthma. Fergusson RJ; Stewart CM; Wathen CG; Moffat R; Crompton GK Thorax; 1995 Jan; 50(1):81-2. PubMed ID: 7886656 [TBL] [Abstract][Full Text] [Related]
73. Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate. Shariare MH; de Matas M; York P Int J Pharm; 2011 Aug; 415(1-2):62-72. PubMed ID: 21683128 [TBL] [Abstract][Full Text] [Related]
74. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®. Hoe S; Young PM; Traini D Drug Dev Ind Pharm; 2011 Nov; 37(11):1365-75. PubMed ID: 21554161 [TBL] [Abstract][Full Text] [Related]
75. Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical Trial. van Meenen DMP; van der Hoeven SM; Binnekade JM; de Borgie CAJM; Merkus MP; Bosch FH; Endeman H; Haringman JJ; van der Meer NJM; Moeniralam HS; Slabbekoorn M; Muller MCA; Stilma W; van Silfhout B; Neto AS; Ter Haar HFM; Van Vliet J; Wijnhoven JW; Horn J; Juffermans NP; Pelosi P; Gama de Abreu M; Schultz MJ; Paulus F JAMA; 2018 Mar; 319(10):993-1001. PubMed ID: 29486489 [TBL] [Abstract][Full Text] [Related]
76. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440 [TBL] [Abstract][Full Text] [Related]
77. In vitro inhalation behaviour and therapeutical response of salbutamol particles administered from two metered dose aerosols. Vidgren P; Silvasti M; Vidgren M; Paronen P; Tukiainen H; Lehti H Pharmazie; 1991 Jan; 46(1):41-3. PubMed ID: 1857729 [TBL] [Abstract][Full Text] [Related]
78. Cardiac effects of salbutamol given by air driven nebuliser at home. Gilmartin JJ; Veale D; Murray A; Adams PC; Gibson GJ Thorax; 1986 Apr; 41(4):331-2. PubMed ID: 3738854 [No Abstract] [Full Text] [Related]
79. Fenoterol versus salbutamol nebuliser solution in asthma. Hockley B; Johnson NM Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():543-5. PubMed ID: 6352317 [No Abstract] [Full Text] [Related]
80. Prevalence and risk factors of lactic acidosis in children with acute moderate and severe asthma, a prospective observational study. Ruman-Colombier M; Rochat Guignard I; Di Paolo ER; Gehri M; Pauchard JY Eur J Pediatr; 2021 Apr; 180(4):1125-1131. PubMed ID: 33089387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]